IL6 and neoplasm: Knockdown of Kindlin-1 leads to reduced recruitment of tumor-infiltrating regulatory T cells (Tregs) and attenuated immunosuppressive activity, primarily through downregulation of interleukin-6 (IL-6) secretion.